×
About 54,182 results

ALLMedicine™ Potassium Center

Research & Reviews  22,369 results

The pharmacotherapeutic management of hyperkalemia in patients with cardiovascular dise...
https://doi.org/10.1080/14656566.2021.1891223
Expert Opinion on Pharmacotherapy; Tamargo J, Caballero R et. al.

Feb 23rd, 2021 - Introduction: Patients with cardiovascular diseases (CVD) are at increased risk of hyperkalemia, particularly when treated with renin-angiotensin-aldosterone inhibitors (RAASIs). Because the occurrence or fear of hyperkalemia, RAASIs are frequentl...

A meet-up of two second messengers: the c-di-AMP receptor DarB controls (p)ppGpp synthe...
https://doi.org/10.1038/s41467-021-21306-0 10.1007/s00294-017-0734-3 10.1007/s00239-019-09915-2 10.1016/S0079-6603(03)75008-9 10.1074/jbc.RA119.008774 10.1016/j.tim.2017.09.003 10.1126/scisignal.aal3011 10.1146/annurev-micro-020518-115943 10.1093/nar/gkaa112 10.1038/nchembio.1363 10.1074/jbc.M114.619619 10.1016/j.cell.2014.07.046 10.1111/febs.13584 10.1016/S0968-0004(96)30046-7 10.1111/mmi.13456 10.1126/scisignal.aaf7279 10.1111/mmi.13412 10.1038/nrmicro3448 10.1016/j.chom.2015.05.006 10.1006/jmbi.1999.3420 10.1007/s00203-005-0078-0 10.3389/fmicb.2020.00277 10.1021/bi0505316 10.1111/j.1365-2958.2007.06018.x 10.1073/pnas.1505271112 10.1038/nature17675 10.1016/S1097-2765(03)00266-1 10.1038/sj.emboj.7600423 10.1016/j.jmb.2014.12.013 10.1074/jbc.M109.040238 10.1073/pnas.1416485112 10.1074/jbc.M114.598300 10.1073/pnas.1522179113 10.1038/s41467-019-10409-4 10.1038/s41467-019-13764-4 10.1038/ncomms11423 10.1093/nar/gky1201 10.1099/mic.0.075226-0 10.1073/pnas.0609897104 10.1111/j.1365-2958.2009.06704.x 10.1074/mcp.M113.032631 10.1128/JB.00028-19 10.1128/mBio.01625-20 10.1111/mmi.13040 10.1371/journal.pgen.1008275 10.1128/JB.177.9.2403-2407.1995 10.1006/abio.1997.2516 10.1111/j.1365-2958.2011.07777.x 10.1016/j.celrep.2020.108157 10.1016/j.cels.2016.12.013 10.1046/j.1432-1033.2003.03935.x 10.1128/JB.179.4.1329-1336.1997 10.1073/pnas.95.10.5752 10.1128/JB.05360-11 10.1016/0003-2697(76)90527-3 10.1021/ac950914h 10.1021/ac026117i 10.1038/nprot.2007.261 10.1099/mic.0.26078-0 10.1093/nar/gky1106
Nature Communications; Krüger L, Herzberg C et. al.

Feb 23rd, 2021 - Many bacteria use cyclic di-AMP as a second messenger to control potassium and osmotic homeostasis. In Bacillus subtilis, several c-di-AMP binding proteins and RNA molecules have been identified. Most of these targets play a role in controlling po...

Corrigendum: A novel mutation in the KCNJ8 gene encoding the Kir6.1 subunit of an ATP-s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882164
Journal of the European Academy of Dermatology and Venere... Chihara M, Asahina A et. al.

Feb 22nd, 2021 - The cannabinoid CB1 receptor (CB1R) has been shown in preclinical studies to be involved in nicotine reinforcement and relapse-like behavior. The common single nucleotide polymorphism (SNP) rs2023239 may code for an alternative CB1R protein, alter...

Short-term mortality risk of different plasma potassium levels in patients treated with...
https://doi.org/10.1177/2047487320925220
European Journal of Preventive Cardiology; Krogager ML, Torp-Pedersen C

Feb 21st, 2021 - Short-term mortality risk of different plasma potassium levels in patients treated with combination antihypertensive therapy.|2021|Krogager ML,Torp-Pedersen C,|

Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensiti...
https://doi.org/10.1177/2047487320926780
European Journal of Preventive Cardiology; Severino P, D'Amato A et. al.

Feb 21st, 2021 - Ischaemic heart disease is classically associated with coronary artery disease. Recent evidences showed the correlation between coronary microvascular dysfunction and ischaemic heart disease, even independently of coronary artery disease. Ion chan...

see more →

Guidelines  29 results

Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease - AMBER
https://www.acc.org/latest-in-cardiology/clinical-trials/2019/10/08/14/26/amber

Oct 7th, 2019 - The AMBER trial showed that the potassium binder patiromer was effective at allowing more patients to remain on spironolactone.

Cilantro leaf harbors a potent potassium channel-activating anticonvulsant
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad180959
FASEB J; Manville RW,et al

Sep 30th, 2019 - Herbs have a long history of use as folk medicine anticonvulsants, yet the underlying mechanisms often remain unknown. Neuronal voltage-gated potassium channel subfamily Q (KCNQ) dysfunction can cause severe epileptic encephalopathies that are res...

American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion i...
https://www.thyroid.org/wp-content/uploads/statements/thy.2017.0054.pdf
Angela M. Leung

Nov 6th, 2017 - This document serves to summarize the issues and the American Thyroid Association (ATA) position regarding the use of potassium iodide as a thyroid blocking agent in the event of a nuclear accident. The purpose is to provide a review and updated p.

American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingest...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561443
Thyroid : Official Journal of the American Thyroid Associ... Leung AM, Bauer AJ et. al.

May 25th, 2017 - This document serves to summarize the issues and the American Thyroid Association (ATA) position regarding the use of potassium iodide as a thyroid blocking agent in the event of a nuclear accident. The purpose is to provide a review and updated p...

A Delphi consensus panel on nutritional therapy in chronic kidney disease.
https://doi.org/10.1007/s40620-016-0323-4
Journal of Nephrology; Bellizzi V, Bianchi S et. al.

Jun 21st, 2016 - The conservative management of chronic kidney disease (CKD) includes nutritional therapy (NT) with the aim to reduce the intake of proteins, phosphorus, organic acids, sodium, and potassium, while ensuring adequate caloric intake. While there is e...

see more →

Drugs  3,883 results see all →

Clinicaltrials.gov  26,981 results

The pharmacotherapeutic management of hyperkalemia in patients with cardiovascular dise...
https://doi.org/10.1080/14656566.2021.1891223
Expert Opinion on Pharmacotherapy; Tamargo J, Caballero R et. al.

Feb 23rd, 2021 - Introduction: Patients with cardiovascular diseases (CVD) are at increased risk of hyperkalemia, particularly when treated with renin-angiotensin-aldosterone inhibitors (RAASIs). Because the occurrence or fear of hyperkalemia, RAASIs are frequentl...

A meet-up of two second messengers: the c-di-AMP receptor DarB controls (p)ppGpp synthe...
https://doi.org/10.1038/s41467-021-21306-0 10.1007/s00294-017-0734-3 10.1007/s00239-019-09915-2 10.1016/S0079-6603(03)75008-9 10.1074/jbc.RA119.008774 10.1016/j.tim.2017.09.003 10.1126/scisignal.aal3011 10.1146/annurev-micro-020518-115943 10.1093/nar/gkaa112 10.1038/nchembio.1363 10.1074/jbc.M114.619619 10.1016/j.cell.2014.07.046 10.1111/febs.13584 10.1016/S0968-0004(96)30046-7 10.1111/mmi.13456 10.1126/scisignal.aaf7279 10.1111/mmi.13412 10.1038/nrmicro3448 10.1016/j.chom.2015.05.006 10.1006/jmbi.1999.3420 10.1007/s00203-005-0078-0 10.3389/fmicb.2020.00277 10.1021/bi0505316 10.1111/j.1365-2958.2007.06018.x 10.1073/pnas.1505271112 10.1038/nature17675 10.1016/S1097-2765(03)00266-1 10.1038/sj.emboj.7600423 10.1016/j.jmb.2014.12.013 10.1074/jbc.M109.040238 10.1073/pnas.1416485112 10.1074/jbc.M114.598300 10.1073/pnas.1522179113 10.1038/s41467-019-10409-4 10.1038/s41467-019-13764-4 10.1038/ncomms11423 10.1093/nar/gky1201 10.1099/mic.0.075226-0 10.1073/pnas.0609897104 10.1111/j.1365-2958.2009.06704.x 10.1074/mcp.M113.032631 10.1128/JB.00028-19 10.1128/mBio.01625-20 10.1111/mmi.13040 10.1371/journal.pgen.1008275 10.1128/JB.177.9.2403-2407.1995 10.1006/abio.1997.2516 10.1111/j.1365-2958.2011.07777.x 10.1016/j.celrep.2020.108157 10.1016/j.cels.2016.12.013 10.1046/j.1432-1033.2003.03935.x 10.1128/JB.179.4.1329-1336.1997 10.1073/pnas.95.10.5752 10.1128/JB.05360-11 10.1016/0003-2697(76)90527-3 10.1021/ac950914h 10.1021/ac026117i 10.1038/nprot.2007.261 10.1099/mic.0.26078-0 10.1093/nar/gky1106
Nature Communications; Krüger L, Herzberg C et. al.

Feb 23rd, 2021 - Many bacteria use cyclic di-AMP as a second messenger to control potassium and osmotic homeostasis. In Bacillus subtilis, several c-di-AMP binding proteins and RNA molecules have been identified. Most of these targets play a role in controlling po...

Corrigendum: A novel mutation in the KCNJ8 gene encoding the Kir6.1 subunit of an ATP-s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882164
Journal of the European Academy of Dermatology and Venere... Chihara M, Asahina A et. al.

Feb 22nd, 2021 - The cannabinoid CB1 receptor (CB1R) has been shown in preclinical studies to be involved in nicotine reinforcement and relapse-like behavior. The common single nucleotide polymorphism (SNP) rs2023239 may code for an alternative CB1R protein, alter...

Topcare sensitive extra whitening - potassium nitrate, sodium fluoride paste, dentifrice-TOPCO Assoc. LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=835f41cf-e920-7df7-e053-2a91aa0a4479

Feb 22nd, 2021 - Uses builds increasing protection against painful sensitivity of the teeth to cold, heat, acids, sweets or contact aids in the prevention of dental cavitiesPurpose Antihypersensitivity Anticavity

Xywav - (calcium, magnesium, potassium, and sodium oxybates) solution-Jazz Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e0ae43a-037f-42af-8e23-a0e51d75abe8

Feb 22nd, 2021 - XYWAV is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. XYWAV is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytim...

see more →

News  859 results

Updated: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium /Hydrochlorothiazide Tablets, USP | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-issues-voluntary-nationwide-recall-losartan-potassium-0

Summary Company Announcement Date: March 01, 2019 FDA Publish Date: March 01, 2019 Product Type: Drugs Prescription Drugs Reason for Announcement: Recall Reason Description Due to The Detection of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Com...

Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyri...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vivimed-life-sciences-pvt-ltd-issues-voluntary-nationwide-recall-losartan-potassium-25-mg-50-mg-and

Summary Company Announcement Date: May 03, 2019 FDA Publish Date: May 03, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to the detection of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Company Name: Vivimed Brand...

Isotonic Fluids Without Potassium Could Be Harmful for Some Acutely Ill Kids
https://www.medscape.com/viewarticle/939875

Oct 27th, 2020 - NEW YORK (Reuters Health) - A recent move to use isotonic rather than hypotonic intravenous fluids (IVFs) in acutely ill children could be boosting their risk of developing electrolyte disorders, a new trial suggests. "Commercially available isoto...

Novel Drug Slows Progression of Diabetic Kidney Disease
https://www.staging.medscape.com/viewarticle/939724

Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...

Novel Drug Slows Progression of Diabetic Kidney Disease
https://www.medscape.com/viewarticle/939724

Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...

see more →

Patient Education  61 results see all →